ClotTriever Outcomes (CLOUT) Registry
Status: | Enrolling by invitation |
---|---|
Conditions: | Cardiology, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 7/20/2018 |
Start Date: | August 1, 2018 |
End Date: | August 1, 2022 |
Evaluate real world patient outcomes after treatment of acute and non-acute lower extremity
deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.
deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.
Inclusion Criteria:
- Lower extremity DVT involving the femoral, common femoral, iliac veins or inferior
vena cava (IVC), alone or in combination.
Exclusion Criteria:
- Prior venous stent in the target venous segment
- Poor inflow to the treated segments
- IVC aplasia/hypoplasia or other congenital anatomic anomalies of the IVC or iliac
veins
- Diagnosed or suspected PE with hemodynamic instability any time within 3 months of the
planned index procedure
- PE signs or symptoms within 3 months of the planned index procedure without CTPA
assessment performed within 7 days of the planned index procedure
- Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast
agents, except for mild to moderate contrast allergies for which pretreatment can be
used
- Life expectancy less than 1 year
- Chronic non-ambulatory status
- Known hypercoagulable states that, in the opinion of the Investigator, cannot be
medically-managed throughout the study period
- Unavailability of a lower extremity venous access site
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials